Year archive

Calliditas Therapeutics — 2018 filings

All 14 regulatory filings released by Calliditas Therapeutics (CALTX) in 2018, sourced directly from the official regulator.

14 Filings

2018 Period

2018 filings (14)

Filing	Released	Lang
Bulletin from extraordinary shareholders’ meeting of Calliditas Therapeutics AB (publ) AGM Information	2018-12-14	English
Kommuniké från extra bolagsstämma i Calliditas Therapeutics AB (publ) AGM Information	2018-12-14	Swedish
Major Shareholding Notification 2018 Major Shareholding Notification	2018-11-29	English
Kallelse till extra bolagsstämma i Calliditas Therapeutics AB (publ) AGM Information	2018-11-14	Swedish
Notice of extraordinary shareholders’ meeting of Calliditas Therapeutics AB (publ) AGM Information	2018-11-14	English
Första patienten rekryterad till den registreringsgrundande kliniska fas 3-studien NEFIGARD med ledande läkemedelskandidaten Nefecon Investor Presentation	2018-11-13	Swedish
First patient enrolled in pivotal clinical phase 3 study NEFIGARD with lead candidate Nefecon Earnings Release FY 2018	2018-11-13	English
Interim / Quarterly Report 2018 Interim / Quarterly Report 9M 2018	2018-11-01	Swedish
Interim / Quarterly Report 2018 Interim / Quarterly Report 9M 2018	2018-11-01	English
Calliditas Therapeutics’ nomination committee for the AGM 2019 AGM Information	2018-10-04	English
Calliditas Therapeutics valberedning utsedd inför årsstämma 2019 Board/Management Information	2018-10-04	Swedish
Major Shareholding Notification 2018 Major Shareholding Notification	2018-08-01	English
Major Shareholding Notification 2018 Major Shareholding Notification	2018-07-31	English
Major Shareholding Notification 2018 Major Shareholding Notification	2018-07-03	English